MeiraGTx Holdings (MGTX) Payables (2017 - 2025)
MeiraGTx Holdings posted quarterly Payables of $34.7 million for Q4 2025, up 47.18% year-on-year from $23.6 million in Q4 2024, and down 63.69% on a QoQ basis from $95.6 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 9 years of Payables data on file, last reported at $34.7 million in Q4 2025.
- For the quarter ending Q4 2025, Payables rose 47.18% year-over-year to $34.7 million; the trailing twelve-month figure through Dec 2025 stood at $34.7 million (up 47.18% YoY), and the FY2025 full-year result was $34.7 million, up 47.18% from the prior year.
- Payables for Q4 2025 stood at $34.7 million, down from $95.6 million in the prior quarter.
- Across five years, Payables topped out at $95.6 million in Q3 2025 and bottomed at $7.9 million in Q1 2021.
- The 5-year median for Payables is $21.0 million (2023), against an average of $24.4 million.
- The widest annual swing landed in 2021, when Payables surged 276.91%; it then fell 28.67% in 2024.
- A 5-year view of Payables shows it stood at $15.3 million in 2021, then gained by 8.26% to $16.6 million in 2022, then slipped by 3.45% to $16.0 million in 2023, then jumped by 47.03% to $23.6 million in 2024, then jumped by 47.18% to $34.7 million in 2025.
- The last three Payables figures came in at $34.7 million (Q4 2025), $95.6 million (Q3 2025), and $25.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 126.63 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 34.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.71 Mn |
| Sep 30, 2025 | 95.59 Mn |
| Jun 30, 2025 | 25.59 Mn |
| Mar 31, 2025 | 20.29 Mn |
| Dec 31, 2024 | 23.59 Mn |
| Sep 30, 2024 | 29.50 Mn |
| Jun 30, 2024 | 21.40 Mn |
| Mar 31, 2024 | 21.22 Mn |
| Dec 31, 2023 | 16.04 Mn |
| Sep 30, 2023 | 20.77 Mn |
| Jun 30, 2023 | 28.50 Mn |
| Mar 31, 2023 | 29.76 Mn |
| Dec 31, 2022 | 16.62 Mn |
| Sep 30, 2022 | 21.69 Mn |
| Jun 30, 2022 | 18.11 Mn |
| Mar 31, 2022 | 18.50 Mn |
| Dec 31, 2021 | 15.35 Mn |
| Sep 30, 2021 | 11.42 Mn |
| Jun 30, 2021 | 11.64 Mn |
| Mar 31, 2021 | 7.90 Mn |
| Dec 31, 2020 | 7.13 Mn |
| Sep 30, 2020 | 5.20 Mn |
| Jun 30, 2020 | 3.09 Mn |
| Mar 31, 2020 | 7.29 Mn |
| Dec 31, 2019 | 3.76 Mn |
| Sep 30, 2019 | 3.80 Mn |
| Jun 30, 2019 | 3.23 Mn |
| Mar 31, 2019 | 3.38 Mn |
| Dec 31, 2018 | 3.04 Mn |
| Sep 30, 2018 | 2.42 Mn |
| Jun 30, 2018 | 3.46 Mn |
| Dec 31, 2017 | 8.50 Mn |